Quick Links

 Gastrointestinal Carcinoid Tumors Research and Clinical Trials

City of Hope is a leader in cancer research, driven to bring the latest scientific findings into clinical practice as quickly as possible. With our extensive number of clinical trials, patients here have access to new treatments that are not yet available elsewhere.

Currently, treatments being tested in clinical trials include:

  • Biologic therapy Biologic therapy uses the patient’s immune system to fight cancer. Substances made by the body or scientifically produced are used to boost, direct or restore the body’s natural defenses against cancer. This type of cancer treatment is also called biotherapy or immunotherapy.
  • Novel Drug Therapies Chemotherapy can be of benefit if other treatment modalities are not applicable. Novel chemotherapeutic drugs such as streptozotocin, 5-fluorouracil and doxorubicin have activity against carcinoid tumors. Sandostatin, which may be given as a month intramuscular injection, is often helpful with controlling symptoms associated with the carcinoid syndrome such as diarrhea and flushing.

To learn more about our clinical trials program and specifically about trials for gastrointestinal carcinoid tumors, click here.

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.